William Slayton, MD - Research

Research at a glance

Top areas of exploration

Hematopoietic Stem Cells , 12 publications
Bone Marrow Transplantation , 10 publications
Bone Marrow Cells , 9 publications
Hematopoietic Stem Cell Transplantation , 8 publications

Research activity

86 publications

2,301 citations

Why is this important?

Active clinical trials

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refrac

This phase II trial tests the safety and best dose of revumenib in combination with chemotherapy, and evaluates whether this treatment improves the outcome in infants and young children who have leukemia that has come back (relapsed) or does not鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: 1 Month - 6 Years
Sexes: All

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: N/A - 50 Years
Sexes: All

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: 3 Years - 29 Years
Sexes: All

My publications

86 publications

2015

Near Fatal Presentation of Neuro-Degenerative Langerhans Cell Histiocytosis

Pediatric Blood & Cancer

2015

Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma.

Leukemia & lymphoma

鈥�

2015

Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome.

Leukemia research reports

鈥�

2014

Bartonella henselae infection inducing hemophagocytic lymphohistiocytosis in a kidney transplant recipient.

Pediatric transplantation

2014

Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia.

Frontiers in oncology

鈥�

网红黑料